triamcinolone acetonide · Pacira Pharms Inc · NDA 208845
Zilretta
Earliest generic entry, as listed
4 Aug 2031
Blocked by patent: US 8828440, US 9555048.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8828440 | product | 4 Aug 2031 |
| US 9555048 | use U-2151 | 4 Aug 2031 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208845 · 001 · RLD | for suspension, extended release, intra-articular | 32MG/VIAL | 4 Aug 2031 |